Outpace Bio

Outpace Bio

Biotechnology Research

Seattle, Washington 4,188 followers

Revolutionizing Cell Therapy with Protein Design

About us

Outpace is creating cell therapies with curative potential through protein design and cellular engineering. With an initial focus on solid tumors, Outpace is developing technologies that overcome the barriers to efficacy and safety by programming cells to make the right decisions inside patients. Outpace’s suite of technologies drive persistent activity of the cell therapy (OutLast™), recruit a productive immune response in the tumor microenvironment (OutSmart™), and achieve the potency (OutSpacers™), specificity (Co-LOCKR™), and safety (EGFRopt™) necessary to unlock diverse cancer indications. Outpace’s internal and partnered pipeline approach is optimized for rapid clinical validation of its technologies across diverse cell types and manufacturing processes. At Outpace Bio, we believe that the highest performing teams include people from a wide variety of backgrounds and experiences who respectfully challenge each other. We are committed to building an open, diverse, and inclusive culture for all employees.

Website
http://www.outpacebio.com
Industry
Biotechnology Research
Company size
51-200 employees
Headquarters
Seattle, Washington
Type
Privately Held
Founded
2020
Specialties
Cell Therapy, Protein Design, Cell Engineering, Cytokines, and Immuno-oncology

Locations

  • Primary

    700 Dexter Ave N

    Suite 300

    Seattle, Washington 98109, US

    Get directions

Employees at Outpace Bio

Updates

Similar pages

Browse jobs

Funding